![](https://news.europawire.eu/wp-content/uploads/2014/05/Technische-Universitaet-Muenchen-and-Helmholtz-Zentrum-Muenchen-discovered-new-approaches-for-stabilizing-antibodies-by-comparing-150x150.jpeg)
Genetically engineered antibodies are deployed successfully in cancer diagnostics and therapy. Therapeutic antibodies against Alzheimer’s disease and multiple sclerosis are currently under development. An important criterion when designing suitable antibody fragments is their stability. Comparing the antibodies of sharks, which … Read the full press release